Main menu

The visit by HRH Crown Princess Mary for the renaming of the Centre was a tribute to the quality of the work we do

Our patients enjoy a panoramic view during radiation therapy treatment

Health in our hands – treating our patients with compassion, dignity and respect
and gaining a better understanding of their needs

For decades the facility at Westmead has been a leading Australian centre for treatment, teaching and research.

Multi-Disciplinary Team Care Approach: Wouldn't you prefer it if all of your specialists were talking to each other,
deciding on the best treatment for you?

Translational cancer research, sees researchers working very closely with clinicians
to improve outcomes for our patients

The Crown Princess Mary Cancer Centre Westmead
Internationally accredited as a ESMO Designated Center of Integrated Oncology and Palliative Care

Introducing Professor Anna deFazio, Sydney West Chair in Translational Cancer Research
who is pioneering groundbreaking research into ovarian cancer.

Care Coordinators - dedicated to helping in all aspects of disease treatment and side-effects.



About Us

The Westmead Melanoma Program is a multidisciplinary service involving collaboration between medical and surgical teams to provide a full range of services for the management of melanoma, including prevention, early diagnosis, surgical and medical treatments and palliative care. The Westmead Melanoma Program members assess and manage patients who have different stages of melanoma.  This means that we not only treat melanoma of the skin, we also treat melanoma that has spread to other parts of the body.

Our mutual goal is to provide optimal care to patients in the Western Sydney area and the wider community who will benefit from services such as dermatology, surgical oncology, medical oncology and radiation oncology. Our team provides education on prevention, diagnosis, monitoring and treatments for melanoma. The Westmead Melanoma Program participates in various research projects with a goal to educate other health professionals and to ultimately benefit patients.

The clinicians of the Westmead Melanoma Service are affiliated with various prestigious research and teaching institutions such as:

  1. The Melanoma Institute of Australia
  2. The University of Sydney
  3. The Westmead Institute of Medical Research
  4. The Skin and Cancer Foundation Australia

The Westmead Melanoma Program participates in national and international clinical trials and research projects, and the clinical and research staff regularly attend conferences world-wide where their ground-breaking research is showcased.

Melanoma Institute Australia (MIA)

Many of the staff of the The Westmead Melanoma Program are also staff, members and affiliates of the Melanoma Institute Australia.

MIA is a non-profit organisation dedicated to preventing and curing melanoma through innovative, world-class research, treatment and education programs. A number of MIA staff are based within the Westmead Melanoma Program, improving the care of patients with melanoma treated at Westmead and ensuring patients of the service have access to world leading research led by MIA. One such position is the Westmead Melanoma Clinical Nurse Consultant, whose position is funded by MIA.

MIA is a national affiliated network of melanoma researchers and clinicians based at the Poche Centre in North Sydney and is closely affiliated with both the University of Sydney and Macquarie University.  MIA is also the home of the world’s largest biospecimens resource (tissue and blood specimens from patients with melanoma). Its clinical database is the world’s largest and extends back to the 1960s. It contains over 60,000 patients and has been used as the backbone for the international staging system for melanoma that is used by clinicians throughout the world. MIA continues to foster laboratory and clinical research, using Westmead Hospital as one of its major hubs. Our clinical trials, including pioneering trials of BRAF inhibitors and immune check-point inhibitors, both conducted at Westmead, have led directly to life-saving new melanoma treatments on the PBS, including dabrafenib, trametinib and pembrolizumab.

Westmead is also the home of MIA’s long-standing investigations into the genetic basis of melanoma and the management of familial melanoma through the Australian Melanoma Family Study

Referral Process

The Westmead Melanoma Program referrals are triaged by our medical staff.  Please send us a referral with as much information as possible to assist us with managing your referral appropriately.

How to refer

Please ask your doctor (e.g GP or Specialist) to contact us by one of the following:

  • Fax us a referral to 02 8890 8567.
  • Postal mail – The Crown Princess Mary Cancer Centre Westmead, PO Box 533  Wentworthville  2145

Urgent Referrals

For urgent referrals, a referring doctor can phone the Crown Princess Mary Cancer Centre Westmead on 02 8890 5200 to speak to the Surgical Oncology Clinical Nurse Consultant, Westmead Melanoma Clinical Nurse Consultant or the relevant clinician; or phone Westmead Hospital 02 (8890 5555) and ask for the Dermatology Registrar on-call.

Routine Referrals

All referrals must include:

  1. Level of urgency
  2. Name, age, date of birth
  3. Address
  4. Contact telephone numbers
  5. Medicare number
  6. Specific clinical problems requiring consultation
  7. Preferred Language. Please indicate if interpreter is needed
  8. Copy of results of relevant investigations performed within the previous 12 months
  9. List of current medications


Dermatology clinics are located in the Department of Dermatology (D5a), all other clinics are located in the Crown Princess Mary Cancer Centre, Westmead Hospital.

  • General Dermatology

This clinic is a general dermatology clinic where a patient with a skin lesion suspicious of skin cancer can be seen by a dermatology team. The patient needs to be referred by a General Practitioner.

  • High Risk Melanoma Clinic (A/Professor Fernandez-Penas)


    A/Professor Fernandez-Penas

This clinic is a dermatology clinic designed to maximise skin cancer and melanoma detection rate by performing full body photography, sequential digital dermoscopy and regular full skin examinations for patients who would be considered high risk of developing another melanoma. For detailed information on the availability and the cost involved in attending the clinic, please ring us on 8890 5686 or email us on

  • Oncodermatology Clinic (A/Professor Fernandez-Penas)

This clinic is a dermatology clinic specifically designed to treat oncology patients who develop skin side effects from oncology systemic drugs. The clinic is open from 8:30am to 4:30pm Mondays, Tuesdays and Thursdays.

Once a patient is referred to onco-dermatology clinic, our dermatology medical team will review the patient and provide appropriate treatment for the patient’s condition. Our onco-dermatology team conducts multiple research projects and clinical data collected from patients may be used for research purposes if informed consent is given by the patient.

  • Surgical Oncology Clinic (Dr Julie Howle, Dr Eva Wong, Dr Muzib Abdul Razak)

Dr Julie Howle

Dr Julie Howle

Dr Eva Wong

Dr Eva Wong

Dr Muzib Abdul Razak

Dr Muzib Abdul Razak

This clinic is a surgical speciality clinic where melanoma patients who require surgery are seen before and after surgical treatment.

  • Medical Oncology Clinic (Dr Matteo Carlino, Professor Richard Kefford)

Dr Matteo Carlino

Dr Matteo Carlino

Prof Richard Kefford

Prof Richard Kefford

In the medical oncology clinic, patients with advanced melanoma or high risk resected melanoma are seen for consideration of systemic therapy more commonly known as chemotherapy. The medical oncology team have had a leading role in the development the two recent significant developments in the treatment of melanoma: targeted and immunotherapy. Patients attending the medical oncology clinic continue to be offered the opportunity to participate in clinical trials of new drugs and drug combinations.

  • Radiation Oncology Clinic (Dr Tim Wang) 
    Dr Tim Wang

    Dr Tim Wang

    Patients with melanoma may benefit from adjuvant radiotherapy to prevent local or regional relapse after surgical resection of primary melanoma or any nodal disease. Also patients with metastatic melanoma also benefit from palliative radiotherapy or stereotactic radiosurgery for symptom palliation or local disease control of metastatic disease. This clinic is a new patient and follow up clinic for patients with melanoma requiring radiotherapy treatment.


(click on specialist name for further details)


  • Dermatologist, Head of Department; A/Professor Pablo Fernandez-Penas
  • Dermatology Clinical Trials & Research Unit Manager; Marina Ali
  • Dermatology Clinical Research Fellows
  • Dermatology Registrars
  • Dermatology Research Team secretary; Rupal Patel

Surgical Oncology

Medical Oncology

Radiation Oncology

  • Radiation Oncologists; Dr Tim Wang
  • Radiation Oncology Registrars

Clinical Nurse Consultants (CNC)

  • Sue-Ellen Delforce- Surgical Oncology CNC
  • Nicki Taylor- Advanced Melanoma CNC


Visit us on Facebook